We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A new test to diagnose bacterial meningitis is fast and effective, can be produced for approximately US $1, and does not require any fancy laboratory equipment, not even a refrigerator.
Public Citizen Sep. 6 urged the Centers for Medicare & Medicaid Services (CMS) not to reimburse for the surgically implanted Vagus Nerve Stimulation (VNS) electronic device in the treatment of severe depression because it is ineffective.
Johnson & Johnson has been put on the defensive after the release of research that called into question the safety of a medical device pioneered by J&J.
Baxter Healthcare is conducting a lot-specific recall of its 500-mL Cryocyte freezing containers. The recall follows an "increased number of customer complaints for cracks or breakages found in the containers during the thawing process," the company said.
The FDA may be making life easier for researchers conducting studies in emergency settings when patients are unable to give their informed consent, issuing a draft guidance on informed consent exceptions Aug. 29.
Small Bone Innovations, Inc. (SBi), a single-source provider of products, technology and education for the small bone and joint sector of the orthopedic industry, has received its CE Certificates and has completed all necessary steps to certify its quality system and devices.
Mayo Clinic researchers have found that an asthma diagnostic test, the exhaled nitric oxide test, is an inexpensive, quick and easy way to determine whether inhaled corticosteroids will relieve a patient's chronic cough.
Vasogen, a leader in the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, announced that new data from the 2,400-patient ACCLAIM trial in chronic heart failure showed that in a major combined subgroup of New York Heart Association (NYHA) Class III/IV patients with no prior history of heart attack and all Class II patients, together comprising more than 50% of the study population, Vasogen's Celacade technology reduced the risk of death and cardiovascular hospitalization by 31% (n= 1,305 patients, p=0.0003).
Researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech have developed a disposable microchip that replaces space-consuming instrumentation with fast, cost-effective, lab-on-a-chip technology.